- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Global Pharmaceuticals & Biotech Undervalued Small Caps With Insider Buying
Results
6
2 new
Smaller, under-the-radar companies, backed by insider buying, presenting a compelling opportunity for investors seeking undervalued gems.
6 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
CDXC | US$5.42 | -7.7% | 256.6% | US$436.0m | US$7.96 | PE279.4x | E81.8% | n/a | ||
APLLTD New | ₹803.40 | -1.8% | -23.4% | ₹157.9b | ₹1,062.58 | PE26.1x | E24.0% | 1.4% | ||
2005 | HK$3.32 | 1.2% | -25.7% | HK$9.8b | HK$5.74 | PE7.2x | E6.6% | 5.4% | ||
6826 New | HK$26.70 | 1.5% | 2.6% | HK$13.1b | HK$42.57 | PE13.6x | E20.1% | 3.2% | ||
MCAP | SEK 392.00 | -1.3% | 0.5% | SEK 5.9b | SEK 535.00 | PE28.3x | S12.9% | n/a | ||
SNDL | US$1.77 | -4.8% | 29.2% | US$467.3m | US$3.18 | PS0.7x | E144.4% | n/a |
Page 1 of 1